Resolution of the conflicting theories of prolonged cell viability

Cardiac Reconstructions with Allograft Tissues

Volumn , Issue , 2005, Pages 184-189

  Hopkins, Richard A ^a,b,c,d,e  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c MIRIAM HOSPITAL   (United States)

^d HASBRO CHILDREN'S HOSPITAL   (United States)

^e Collis Cardiovascular Research Laboratory ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871322169     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-26515-5_20     Document Type: Chapter

References (26)

1. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 1998;115:118-127.
2. Hilbert SL, Luna RE, Zhang J, Wang Y, Hopkins RA, Yu ZX, Ferrans VJ. Allograft heart valves: the role of apoptosis-mediated cell loss. J Thorac Cardiovasc Surg 1999;117:454-462.
3. Hufnagel CA, Gomes MN. Late follow-up of ball-valve prostheses in the descending aorta. J Thorac Cardiovasc Surg 1976;72:900-909.
4. Ferrans VJ, Arbustini E, Eidbo EE, et al. Anatomic changes in right ventricularpulmonary artery conduits implanted in baboons. In Bodnar E, Yacoub M (eds). Biologic and Bioprosthetic Valves. New York, NY: Yorke 1986:316.
5. Hilbert SL, Luna RE, Zhang J, et al. Allograft heart valves: assessment of cell viability by confocal microscopy. Circulation 1997;96(Suppl):I508.
6. Mitchell RN, Jonas RA, Schoen F. Structurefunction correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg 1995;60:8108-8133.
7. Schoen FJ, Mitchell RN, Jonas RA. Pathological considerations in cryopreserved allograft heart valves. J Heart Valve Dis 1995;4:S72-S76.
8. Goffin YA, De Gouveia H, Szombathelyi T, et al. Morphologic study of homograft valves before and after cryopreservation and after short term implantation in patients. Cardiovasc Pathol 1997;6:35-42.
9. Gavin JB, Herdson PB, Monro JL, Barratt-Boyes BG. Pathology of antibiotic-treated human heart valve allografts. Thorax 1973;28:473-481.
10. Messier R, Bass BL, Domkowski PW, Hopkins RA. Interstitial Cellular Matrix Restoration of Cardiac Valves Following Cryopreservation. J Thorac Cardiovasc Surg 1999;118:36-49.
11. Rajani B, Uree RB, Ratliff NB. Evidence for rejection of homograft valves in infants. J Thorac Cardiovasc Surg 1998;115:111-117.
12. Vogt P, Stallmach T, Niederhauser U, Schneider J, Zund G, Lachat M, Kunzli A, Turina M. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. EJCTS 1999;15:639-645.
13. Shaddy RE, Thompson DD, Osborne KA, Hawkins J A F T. Persistence of human leukocyte antigen (HLA) immunogenicity of crypreserved valve allografts used in pediatric heart surgery. American Journal of Cardiology 1997;80:358-359.
14. Motomura N, Imakita M, Yutani C, Kitoh Y, Kawashima Y, Oka T. Histological change in cryopreserved rat aortic allograft. Journal of Cardiovascular Pathology 1995;36:53-60.
15. Neves JP, Gulbenkian S, Ramos T, Martins AP, Caldas MC, Mascarenhas R, et al. Mechanisms underlying degeneration of cryopreserved vascular homografts. J Thorac Cardiovasc Surg 1997;113:1014-1021.
16. Neves J, Monteiro C, Santos R, et al. Histologic and genetic assessment of explanted allograft valves. Ann Thorac Surg 1995;60:141-145.
17. Hoekstra FM, Witvliet M, Knoeep CY, Wassenaar C, Boger J J C, Weimar W, Claas F H J. Immunogenic human leukocyte antigen Class II antigens on human cardiac vlave induce specific alloantibodies. Ann Thorac Surg 1998;66:2022-2026.
18. Wagner E, Roy R, Marois Y, Douville Y, Guidoin R. Fresh venous allografts in peripheral arterial reconstruction in dogs: effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil. J Thorac Cardiovasc Surg 1995;110:1723-1744.
19. Christenson JT, Vala D, Dierra J, Beghetti M, Kalangos A. Blood group incompatibility and accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg 2003; In Press.
20. Hoekstra F, Knoop C, Jutte, et al. Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant 1994;13:1095-1098.
21. Hoekstra FM, Witvliet M, Knoop C. Donorspecific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. Journal of Heart and Lung Transplantation 1997;16:570-572.
22. Smith JD, Ogino H, Hunt D, et al. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995;60:S127-S130.
23. Shaddy RE, Hunter DD, Osborn KA. Prospective analysis of HLA immunogenicity of crypreserved valved allografts used in pediatric heart surgery. Circulation 1994;94:1063-1067.
24. Maish MS, Hoffman-Kim D, Krueger PM, Souza JM, Harper JJ, Hopkins RA. Tricuspid Valve Reproducible echocardiography in juvenile sheep and its application in the evaluation of a pulmonary valve allograft implant. Contemporary Topics in Laboratory Animal Science 2000;39:15-21.
25. Conflicting Theories of Prolonged Cell Viability 189 Biopsy-A potential source of cardiac myofibroblast cells for tissue engineered cardiac valves. J Heart Valve Dis 2002; In press.
26. Hong T, Maish MS, Cohen J, Fitzpatrick P, Bert A, Harper J, Hoffman-Kim D, Hopkins RA. Reproducible echocardiography in juvenile sheep and its application in the evaluation of a pulmonary valve allograft implant. Contemporary Topics in Laboratory Animal Science 2000;39:15-21.